Cutaneous anergy in pregnant and nonpregnant women with human immunodeficiency virus

Infectious Diseases in Obstetrics and Gynecology

Volumn 6, Issue 1, 1998, Pages 13-17

  Eriksen, N L ^a   Helfgott, A W ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

HIV; Immunocompromised; TB skin testing; Women

Indexed keywords

CANDIDA ANTIGEN; CD4 ANTIGEN; TETANUS TOXOID; TUBERCULIN; VIRUS ANTIGEN;

ADULT; CLONAL ANERGY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MUMPS VIRUS; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; SKIN TEST; TUBERCULIN TEST;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV SEROPOSITIVITY; HUMANS; IMMUNE TOLERANCE; PREGNANCY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0031810590     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-0997(1998)6:1<13::AID-IDOG4>3.0.CO;2-8     Document Type: Conference Paper

References (22)

1. Rieder HL, Cauthen GM, Kelley GD, Bloch AB, Snider DE: Tuberculosis in the United States. JAMA 262:385-389, 1989.
2. Barnes PF, Bloch AB, Davidson PT, Snider DE: Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 324:1644-1650, 1991.
3. Centers for Disease Control and Prevention: Tuberculosis among pregnant women - New York City 1985-1992. MMWR 42:605-611, 1993.
4. Centers for Disease Control and Prevention: Update: AIDS among Women-United States, 1994. MMWR 44:81-84, 1995.
5. Margono F, Mroueh T, Garely A, White D , Duen A, Minkoff HL: Resurgence of active tuberculosis among pregnant women. Obstet Gynecol 83: 911-914, 1994.
6. Antonucci G, Giardi E, Raviglione MC, Ippolito G: Risk factors for tuberculosis in HIV-infected persons. JAMA 274; 143-148, 1995.
7. Janis EM, Allen DW, Glesby MJ, et al.: Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Am J Med 100:186, 1996.
8. Markowitz N, Hansen NI, Wilcosky TC, Hopewell PC, Glassroth J, Krale PA: Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Int Med 119:185-193, 1993.
9. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF: Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus. Am Rev Respir Dis 148:1292-1297, 1993.
10. Blatt SP, Hendrix CW, Butzin CA, et al.: Delayed type hypersensitivity skin testing predicts progression to AIDS in HIV infected persons. Ann Int Med 119:177-184, 1993.
11. Graham NM, Nelson KE, Solomon L, et al.: Prevalence of tuberculin positivity and skin test anergy in HIV 1 seropositive and sero negative intravenous drug users. JAMA 267:369-373, 1992.
12. Johnstone FD, Thong KJ, Bird AG, Whitelaw J. Lymphocyte sub-populations in early human pregnancy. Obstet Gynecol 83: 941-946, 1994.
13. Burns DN, Nourjah P, Minkoff H, et al.: Changes in CD4+ and CD8+ cell levels during pregnancy and postpartum in women seropositive and seronegative for human immunodeficiency virus-1. Am J Obstet Gynecol 174:1461-1468, 1996.
14. Mofenson LM, Rodriguez EM, Hershow R, et al.: Mycobacterium tuberculosis infection in pregnant and nonpregnant women infected with HIV in the Women and Infants Transmission Study. Arch Int Med 155:1066-1072, 1995.
15. Centers for Disease Control and Prevention: Purified protein derivative (PPD)-Tuberculin anergy and HIV infection: Guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 40:27-33, 1991.
16. Moreno S, Baraia-Etxaburu J, Bouza E, et al.: Risk for developing tuberculosis among anergic patients. Ann Intern Med 119:194-198, 1993.
17. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE: High risk of active tuberculosis in HIV infected drug users with cutaneous anergy. JAMA 268:504-509, 1992.
18. Franks AL, Binkin NJ, Snider DE, Rokaw WM, Becker S: Isoniazid hepatitis among pregnant and post partum patients. Public Health Rep 104:151-155,1989.
19. Miotti PG, Liomba G, Dallabetta GA, Hoover DR, Chiphangwi JD, Saah AJ: T lymphocyte subsets during and after pregnancy: Analysis in human immunodeficiency virus type-1- infected and uninfected Malawian mothers. J Infect Dis 165:1116-1119, 1992.
20. Chin DP, Osmond D, Page-Shafer K, et al.: Reliability of anergy skin testing in persons with HIV infection. Am J Respir Grit Care Med 153:1982-1984, 1996.
21. Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Valhov D: Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus. Arch Int Med 155:2111-2117, 1995.
22. Gordin FM, Matts JP, Miller C, et al.: A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. N Engl J Med 337:315-320, 1997.